Vanguard Personalized Indexing Management
RDY icon

Vanguard Personalized Indexing Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Sell
333,247
-3,331
-1% -$44.9K 0.04% 366
2026
Q1 		$4.66M Buy
336,578
+7,599
+2% +$106K 0.05% 334
2025
Q4 		$4.62M Sell
328,979
-22,490
-6% -$315K 0.05% 332
2025
Q3 		$4.91M Buy
351,469
+56,760
+19% +$817K 0.05% 321
2025
Q2 		$4.43M Buy
294,709
+111,691
+61% +$1.59M 0.05% 326
2025
Q1 		$2.41M Sell
183,018
-7,724
-4% -$107K 0.04% 428
2024
Q4 		$3.01M Sell
190,742
-10,793
-5% -$162K 0.05% 345
2024
Q3 		$3.2M Buy
201,535
+20,505
+11% +$330K 0.05% 324
2024
Q2 		$2.76M Buy
181,030
+25,850
+17% +$371K 0.05% 323
2024
Q1 		$2.28M Buy
155,180
+29,510
+23% +$431K 0.05% 357
2023
Q4 		$1.75M Sell
125,670
-7,200
-5% -$96.3K 0.04% 388
2023
Q3 		$1.78M Buy
132,870
+14,220
+12% +$192K 0.05% 346
2023
Q2 		$1.5M Buy
118,650
+10,935
+10% +$128K 0.05% 400
2023
Q1 		$1.23M Buy
107,715
+25,745
+31% +$278K 0.04% 438
2022
Q4 		$848K Buy
+81,970
New +$884K 0.04% 575
2022
Q2 		– Sell
-18,470
Closed -$206K – 1317
2022
Q1 		$206K Buy
18,470
+975
+6% +$11.1K 0.01% 1118
2021
Q4 		$229K Sell
17,495
-2,555
-13% -$32.2K 0.01% 954
2021
Q3 		$261K Buy
20,050
+810
+4% +$10.8K 0.02% 833
2021
Q2 		$283K Sell
19,240
-23,510
-55% -$329K 0.03% 761
2021
Q1 		$525K Sell
42,750
-3,880
-8% -$49.8K 0.08% 305
2020
Q4 		$665K Buy
46,630
+1,860
+4% +$25K 0.14% 165
2020
Q3 		$623K Buy
44,770
+5,405
+14% +$64.4K 0.17% 139
2020
Q2 		$417K Sell
39,365
-23,845
-38% -$243K 0.19% 133
2020
Q1 		$510K Buy
+63,210
New +$527K 0.3% 92

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Personalized Indexing Management's RDY Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Dr. Reddy's Laboratories (RDY) stake by 0.99% in Q2 2026, selling an estimated $44.9K and leaving 333,247 shares worth $4.83M. The position accounts for 0.04% of the portfolio, ranked #366.

Vanguard Personalized Indexing Management first reported a position in RDY in Q1 2020 and has held it in 24 quarters since. The position peaked at $4.91M in Q3 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Vanguard Personalized Indexing Management held 333,247 shares of Dr. Reddy's Laboratories worth $4.83M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 3,331 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $44.9K.
  • Dr. Reddy's Laboratories made up 0.04% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #366 holding.
  • Vanguard Personalized Indexing Management first reported a position in Dr. Reddy's Laboratories in Q1 2020 and has held it in 24 quarters since.
  • Vanguard Personalized Indexing Management's Dr. Reddy's Laboratories position peaked at $4.91M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.